Amlitelimab for Atopic Dermatitis: Derm Immuno Today Segment
DocWireNews' Derm Immuno Today turns to amlitelimab for atopic dermatitis. The listing carries no trial data; consult the segment for efficacy and pipeline details.
Topic
Topic
DocWireNews' Derm Immuno Today turns to amlitelimab for atopic dermatitis. The listing carries no trial data; consult the segment for efficacy and pipeline details.